ÐÓ°ÉÔ­´´

TearSolutions logo

TearSolutions

TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients.

2

Funding Rounds

$4.5m

Money raised

Overview

TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients.
  • Website:
  • Business model: B2B
  • Social accounts:

Funding series

Funding Series Analysis

The company TearSolutions has raised a total of $3m in funding over 2 rounds.

Key Insights:

  • TearSolutions November 2024 Series B Funding Round: $3m
  • TearSolutions, Inc. funding round, February 2020: $1.5m
TearSolutions logo
TearSolutions November 2024 Series B Funding Round $3m
TearSolutions logo
TearSolutions, Inc. funding round, February 2020 $1.5m

Industries

TearSolutions is active in the following industries: